![Page 1: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/1.jpg)
The role of generic drugs in the
treatment of viral hepatitis
Dr Andrew Hill
University of Liverpool
United Kingdom
2nd International Meeting on Elimination of
Viral Hepatitis, Amsterdam, December 3rd 2016
![Page 2: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/2.jpg)
What is the best
combination of DAAs
to mass produce?
2
![Page 3: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/3.jpg)
7752/8133 33/34 281/361 39/41 24/2561/69
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
G1 G2 G3 G4 G5 G6
Pe
rce
nt
SV
RSofosbuvir + Ledipasvir ± RBV (12-24 wks)
Percentage SVR12, by Genotype
95% 97% 78% 88% 95% 96%
![Page 4: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/4.jpg)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
G1 G2 G3 G4 G5 G6
Pe
rce
nt
SV
R
Grazoprevir + Elbasvir ± RBV ± SOF (12-18 wks)Percentage SVR12, by Genotype
95% 63%93% 74%80% 96%
24/251807/1904 24/30 118/127 5/8 26/35
![Page 5: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/5.jpg)
1459/1575 21/22 296/316 64/70 5/5628/752
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
G1 G2 G3 G4 G5 G6
Pe
rce
nt
SV
RSofosbuvir + Daclatasvir ± RBV (12-24 wks)
Percentage SVR12, by Genotype
93% 95% 84% 94% 91% 100%
![Page 6: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/6.jpg)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
G1 G2 G3 G4 G5 G6
Pe
rce
nt
SV
RSofosbuvir + Velpatasvir ± RBV (12-24 wks)
Percentage SVR12, by Genotype
97% 98% 81% 94% 95% 96%97% 98% 81% 94% 95% 96%97% 98% 81% 94% 95% 96%97% 98% 81% 94% 95% 96%97% 98% 81% 94% 95% 96%96% 99% 90% 100% 97% 100%
749/778 259/261 535/592 128/128 34/35 42/42
![Page 7: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/7.jpg)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
G1 G2 G3 G4 G5 G6
Pe
rce
nt
SV
R
Glecaprevir + Pibrentasvir (12-16 wks)Percentage SVR12, by Genotype
99% 100%99% 100%99% 95%
331/332 195/196 75/76 19/1926/26125/131
![Page 8: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/8.jpg)
How cheaply can
medicines be
produced?
8
![Page 9: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/9.jpg)
ActivePharmaceuticalIngredient
Raw drug substanceDatabase www.indiainfodrive.com shows exports of API from India to other countries, with costs per kilogram of API, for many drugs
9
![Page 10: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/10.jpg)
Cost/kg of sofosbuvir API exports Jan 2015 to Jul 2016, weighted by size of shipment
Gotham D, Barber M, Fortunak J, Pozniak A, Hill A.
Abstract number A-792-0516-01639, presented at AIDS2016, Durban.
![Page 11: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/11.jpg)
From API cost/kg to target price
API price/kg x grams per treatment course
+ $0.04 / tablet for excipients and tableting,
+ $0.35/month for formulation
x 10-50% profit margin
(10% for mass-produced drugs e.g. HIV, TB)
11Gotham D, Barber M, Fortunak J, Pozniak A, Hill A.
Abstract number A-792-0516-01639, presented at AIDS2016, Durban.
![Page 12: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/12.jpg)
Target generic price of sofosbuvir
(12 weeks)
Gotham D, Barber M, Fortunak J, Pozniak A, Hill A.
Abstract number A-792-0516-01639, presented at AIDS2016, Durban.
![Page 13: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/13.jpg)
50
.42
6 €
41
.68
0 €
40
.55
6 €
37
.93
6 €
13
.00
0 €
6.0
08
€
3.4
35
€
28
8 €
55
€
0 €
15.000 €
30.000 €
45.000 €
60.000 €
Ger
man
y
Fran
ce UK
Can
ada
Spai
n
Bra
zil
Au
stra
lia
Ind
ia
Targ
et
pri
ce in
Eu
ros
for
12
-we
ek
cou
rse
Sofosbuvir (Sovaldi)
German price: €50,426
Cost price: €55
Sofosbuvir prices:1. Canada (Quebec): http://www.ramq.gouv.qc.ca/SiteCollectionDocuments/liste_med/liste_med_2016_10_03_fr.pdf2. France: http://www.medecinsdumonde.org/actualites/presse/2016/09/29/mdm-soppose-au-brevet-sur-le-sovaldir-decision-le-5-octobre-2016
3. Germany: medizinfuchs.de4. Spain: http://politica.elpais.com/politica/2016/04/05/actualidad/1459873421_480033.html?id_externo_rsoc=TW_CC6. UK: British National Formulary 20167. Brazil: http://www.portaltransparencia.gov.br/despesasdiarias/empenho?documento=250005000012015NE8014938. Australia: Based on total annual government expenditure (AU$200 million) and 40,000 treated in 20169. India: http://hepcasia.com/wp-content/uploads/2016/03/31-Jan-2016-Indian-generic-sofosbuvir.pdf
Price of sofosbuvir by country (12 weeks)
![Page 14: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/14.jpg)
Drug Current US price
(lowest)
Current lowest
Indian market
price
Target price
Sofosbuvir $49,680 $324 $62
Daclatasvir $50,653 $153 $14
SOF+LDV $56,700 $507 $96
SOF+VEL $74,760 - $181-216
HCV DAAs: Prices in USA and India versus Target
Gotham D, Barber M, Fortunak J, Pozniak A, Hill A. Rapidly falling costs for new hepatitis C direct-acting antivirals (DAAs): potential for universal access. Abstract number A-792-0516-01639, presented at AIDS2016, Durban.
![Page 15: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/15.jpg)
Prices of HCV DAAs keep falling
SOF and DCV API now being exported from China for $800 per kg
This would lower the basic production price to $55 for 12 weeks of SOF/DCV
In Egypt, SOF/DCV is now available for $172 per 12 weeks (WHO 2016 report)
15
![Page 16: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/16.jpg)
Entecavir for Hepatitis Bone year’s supply (0.2g)
![Page 17: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/17.jpg)
Entecavir for Hepatitis B
cost per person/year by country
Entecavir (Baraclude)
US price: $15,111
Cost price: $36
Published in: Hill et al. Journal of Virus Eradication 2015.
![Page 18: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/18.jpg)
Target versus Global lowest prices:
HIV, TB and Hepatitis
![Page 19: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/19.jpg)
Mass produced HCV DAAs should fall
to <$90 per 12-week course
![Page 20: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/20.jpg)
The new “$90 $90 $90” in 2017
There should be standard prices to treat HIV, Hep B/C and TB
< $90 per year to treat HIV: TDF/3TC/EFV
< $90 per year to treat Hepatitis B: TDF/3TC or ETV
< $90 for first-line treatment for TB
< $90 for 12-weeks course of HCV DAAs: SOF/DCV
TDF/3TC, efavirenz, entecavir and most TB drugs will be generic worldwide in 2017. Prices should then fall in all countries, close to Indian / South African levels.
<$90 price to cure Hepatitis C will only be in low and middle income countries
![Page 21: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/21.jpg)
Could pharmaceutical
companies lower their
prices, but then treat
more people?
21
![Page 22: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/22.jpg)
50
.42
6 €
41
.68
0 €
40
.55
6 €
37
.93
6 €
13
.00
0 €
6.0
08
€
3.4
35
€
28
8 €
55
€
0 €
15.000 €
30.000 €
45.000 €
60.000 €
Ger
man
y
Fran
ce UK
Can
ada
Spai
n
Bra
zil
Au
stra
lia
Ind
ia
Targ
et
pri
ce in
Eu
ros
for
12
-we
ek
cou
rse
Sofosbuvir prices:1. Canada (Quebec): http://www.ramq.gouv.qc.ca/SiteCollectionDocuments/liste_med/liste_med_2016_10_03_fr.pdf2. France: http://www.medecinsdumonde.org/actualites/presse/2016/09/29/mdm-soppose-au-brevet-sur-le-sovaldir-decision-le-5-octobre-2016
3. Germany: medizinfuchs.de4. Spain: http://politica.elpais.com/politica/2016/04/05/actualidad/1459873421_480033.html?id_externo_rsoc=TW_CC6. UK: British National Formulary 20167. Brazil: http://www.portaltransparencia.gov.br/despesasdiarias/empenho?documento=250005000012015NE8014938. Australia: Based on total annual government expenditure (AU$200 million) and 40,000 treated in 20169. India: http://hepcasia.com/wp-content/uploads/2016/03/31-Jan-2016-Indian-generic-sofosbuvir.pdf
Price of sofosbuvir by country (12 weeks)
![Page 23: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/23.jpg)
If drug prices were lower,
could pharmaceutical
companies
still afford
to do R&D?
23
![Page 24: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/24.jpg)
Gilead sales and profits
Cumulative sales of Sovaldi & Harvoni to
3Q 2016:
$40 billion
Profits in 2015:
$18 billion
Reference: Gilead quarterly product sales summaries
![Page 25: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/25.jpg)
Gilead: $10 billion in tax avoidance
25
Washington Post, July 13 2016. Gilead is using Ireland as
a tax haven for global profits.
“The drug company that shocked the world
with its prices dodged $10 billion in taxes”
$10 billion is enough
money to treat 100 million
people with HCV, at the
cost price of $100 each
https://www.washingtonpost.com/news/wonk/wp/2016/07/13/maker-of-84000-drug-avoided-10-billion-in-u-s-taxes-report-says/
![Page 26: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/26.jpg)
Pharma profits and tax avoidanceMain tax havens: Bermuda, Cayman Islands, BVI, Bahamas, Luxembourg, Ireland
26
Company Profits held
offshore
US Taxes
Avoided
Pfizer $69 billion $20 billion
Merck $57 billion $16 billion
Johnson & Johnson $51 billion $14 billion
Amgen $26 billion $9 billion
Abbott $24 billion $7 billion
BMS $24 billion $7 billion
Source: Citizens for Tax Justice, 2016. http://gormanandjoneslaw.com/offshore-tax-havens/http://america.aljazeera.com/articles/2015/3/12/obama-gambit-for-corporate-cayman-cash.html
![Page 27: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/27.jpg)
Options if drugs still patented -
Voluntary licenses
Some pharmaceutical companies allow cheap generics to be sold in certain low and middle income countries, with voluntary licenses. However:
1. China, South America, Russia and Eastern European countries are not included in most of these agreements. As a result, prices in these countries can be unaffordable
2. Other countries may have voluntary licenses but if the company does not register the drug for regulatory approval, then the drug cannot be accessed
3. Merck and AbbVie have no voluntary licenses for their Hepatitis C treatments.
![Page 28: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/28.jpg)
Sofosbuvir voluntary license coverage
![Page 29: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/29.jpg)
A new option for access to treatment:
HIV and Hepatitis C buyers clubs
There are many companies willing to export generic PrEPand DAAs into Europe and North America
Several generic ARVs are already approved by the US Food and Drug Administration and the World Health Organization.
Generic PrEP or DAAs can be bought online in 10 minutes. Prices are falling rapidly.
www.alldaychemist.com
www.iwantprepnow.co.uk
www.fixhepc.com
www.myhepc.info
![Page 30: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/30.jpg)
Patented vs Generic drugs for HCV
Harvoni
€45,000Generic SOF/DCV
€900
Hepatitis C: https://www.youtube.com/watch?v=HBF5cf5zt9U
HIV: https://youtu.be/JXnaHYzyAq4
Routes of export: https://youtu.be/X1QSHkUAP50
![Page 31: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/31.jpg)
The legal basis of personal importation
Article 60 of TRIPS - De Minimis Imports – states:
Members may exclude from the application of the above
provisions small quantities of goods of a non-commercial
nature contained in travellers' personal luggage or sent in
small consignments
In line with Article 60, most countries allow some
form of personal medication importation
Medicines are being sent from India, China, Egypt
and Bangladesh to countries all over the world
![Page 32: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/32.jpg)
FixHepC Buyer’s Club
N = 438RVR: 85 %EOT: 99% SVR4: 89%[Poster 256 –HIV Glasgow 2016]
www.fixhepc.com
![Page 33: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/33.jpg)
Hep C Treatment Without Borders
N = 151RVR: 74 %EOT: 93% SVR4: 96% SVR12: 96%
http://hepatitisctreatment.homestead.com/
![Page 34: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/34.jpg)
34
South East Asia Buyer’s Club
N = 237RVR: 99%EOT: 99%SVR4: 100%SVR12: 92%[Poster 256 –HIV Glasgow 2016]
![Page 35: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/35.jpg)
35
Russian Buyer’s Club
N = 213RVR: 85%EOT: 100%SVR4: 100%SVR12: 98%[Poster 261 –HIV Glasgow 2016]
$490 for
SOF/DCV,
12 weeks
![Page 36: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/36.jpg)
Conclusions
Elimination of disease is only affordable if drugs can be accessed at low prices, within national health budgets
We need new approaches to funding mass treatment programmes for Hepatitis C in Europe:
“All you can Treat” pricing – unlimited treatments for a fixed price
Or
Lower fixed prices. Under €4000 per cure for Hepatitis C.
Most drugs are fundamentally cheap to produce, so pharmaceutical companies can still make large profits from selling to larger numbers of people at lower unit prices.
![Page 37: The role of generic drugs in the treatment of viral hepatitisregist2.virology-education.com/2016/IVHEM/20_Hill.pdf · The role of generic drugs in the treatment of viral hepatitis](https://reader031.vdocuments.net/reader031/viewer/2022013015/5b6d09247f8b9afc538c38c3/html5/thumbnails/37.jpg)
Conclusions
If pharmaceutical companies refuse to lower prices, we
need back-up mechanisms to ensure access:
• Compulsory licenses
• Buyers Clubs
• Windfall taxes on tax avoidance
Recovery of Gilead’s $10 billion in avoided tax alone would
provide sufficient funds to treat everyone with Hepatitis C
worldwide, at cost price of <$90 per person.